“High-Frequency Migraine Refractory to Usual Pharmacological Treatment and Antibody and Responsive to Full-Spectrum Cannabidiol: A Case Report”. Headache Medicine 13, no. 3 (September 30, 2022): 229–232. Accessed January 22, 2026. https://headachemedicine.com.br/hm/article/view/661.